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Abstract Aquaporins are membrane proteins that play fun-
damental roles in water and small solute transport across
epithelial and endothelial barriers. Recent studies suggest that
several aquaporin proteins are present in the mammary gland.
Immunohistochemical techniques have confirmed the pres-
ence of aquaporin 1 (AQP1) and AQP3 water channels in
rat, mouse, bovine and human mammary glands. Studies
suggest that in addition to AQP1 and AQP3 AQP4, AQP5
and AQP7 proteins are expressed in different locations in the
mammary gland. Aquaporins play key roles in tumor biology
and are involved in cell growth, migration and formation of
ascites via increased water permeability of micro-vessels.
Emerging evidence suggests that expression of these proteins
is altered in mammary tumors and in breast cancer cell lines
although it is not yet clear whether this is a cause or a
consequence of neoplastic development. This review analyzes
the expression and potential functional roles of aquaporin
water channels in the mammary gland. The physiological
mechanisms involved in the transport of water and small
solutes across mammary endothelial and epithelial barriers
are discussed in the context of milk production and lactation.
This paper also reviews papers from the recent cancer litera-
ture that implicate aquaporins in mammary neoplasia.
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Introduction
The mammary gland is a milk-producing organ that is charac-
teristic of all female mammals and its overriding function is to
synthesize and deliver milk to the newborn offspring. It is also
present in a rudimentary and nonfunctional form in males. The
mammary gland is a unique and dynamic organ that undergoes
epithelial expansion and invasion during puberty and cycles of
branching and lobular morphogenesis, secretory differentiation,
and regression during pregnancy, lactation, and involution [1].
Embryonically, the mammary gland is derived from the ecto-
derm. Development begins with invasion of the underlying fat
pad by a rudimentary ductal structure [2]. The epithelial nod-
ules become buried in the mesenchyme, where they undergo
differentiation under the influence of paracrine signals from the
mesenchyme. These later develop into a tubuloalveolar struc-
ture that becomes functional in response to the hormonal
changes associated with parturition and regulated by the endo-
crine system. Postnatal growth occurs in two phases: ductal
growth and early alveolar development during estrous cycles,
and cycles of cell proliferation, differentiation, and death that
occur with each pregnancy, lactation, and involution.
In terms of structure, themammary gland is essentially similar
to amodified sweat gland. In humans each fully developed breast
is composed of 15–25 secretory lobes embedded in adipose
tissue. Each secretory lobe is a compound tubular acinar gland.
The acini lead to ducts, which are lined by cuboidal or columnar
epithelial cells that are surrounded by myoepithelial cells. The
ducts from each lobule empty into a lactiferous duct that leads to
the nipple in the ampulla. The development, proliferation and
differentiation of the mammary gland involve the concerted
actions of a variety of hormones and growth factors including
Fig. 1 The mammary gland. a The growth of alveoli from the ducts of
the mammary gland during pregnancy and lactation. Only a small part of
the gland is shown. The “resting” gland contains a small amount of
inactive glandular tissue embedded in a large amount of fatty connective
tissue. During pregnancy an enormous proliferation of the glandular
tissue takes place at the expense of the fatty connective tissue, with the
secretory portions of the gland developing preferentially to create alveoli.
b One of the milk-secreting alveoli with a basket of contractile
myoepithelial cells (green) embracing it. c A single type of secretory
alveolar cell produces both the milk proteins and the milk fat. The
proteins are secreted in the normal way by exocytosis, while the fat is
released as droplets surrounded by plasma membrane detached from the
cell. Figure adapted and re-drawn from Molecular Biology of the Cell.
(4th edition). Bruce Alberts, Dennis Bray, Julian Lewis, Martin Raff,
Keith Roberts, and James D. Watson. New York: Garland Science; 2002
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estrogen, progesterone, and prolactin. In addition to these regu-
latory endocrine factors, normal mammary development and
lactation require cellular communication and cell-cell interactions
between the stromal and parenchymal elements of the mammary
gland [3]. Figure 1 outlines the growth of alveoli from the ducts
of the mammary gland during pregnancy and lactation. This
figure also highlights the differences between “resting”, “preg-
nancy” and “lactating” states and illustrates the functional unit of
the mammary gland consisting of milk-secreting alveoli with a
basket of contractile myoepithelial cells embracing it.
Mammary lobes are comprised of secretory acini, which
are formed from cuboidal epithelial cells, responsible for the
synthesis and secretion of milk, surrounded by myoepithelial
cells. The latter contract during the milk ejection reflex, in-
crease the pressure in acini and stimulate the expulsion of
milk. Interstitial spaces between acini, ducts and lobes are
filled with connective tissue and, for the most part, adipose
tissue. In lactating animals, active acini secrete milk, which
drains into small intralobular excretory ducts. Ducts are also
lined with epithelial cells and may have an outer layer of
myoepithelial cells derived from the same lineage [4, 5]
(Fig. 2). Intralobular ducts join to form a network of interlob-
ular ducts leading into a complex system of lactiferous ducts.
During pregnancy the alveolar duct epithelium proliferates,
resulting in the formation of numerous secretory alveoli,
which begin forming a protein-rich fluid called colostrum.
Fig. 2 a Model alveolus (a) with
subtending duct (d) showing
blood supply, adipocyte stroma,
myoepithelial cells, and plasma
cells (PC). b Histology of human
mammary gland. The sample
shown in this figure is from a
tissue microarray developed by
the Cooperative Human Tissue
Network (CHTN) of the National
Cancer Institute (http://www.chtn.
nci.nih.gov/). Mammary gland
alveoli and ducts form an
extensive network of
interconnected structures
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The formation of milk is one of the key functions of the
mammary gland. Milk consists of simple sugars, lipids, pro-
teins, vitamins and minerals dissolved in water, which makes
up to 88 % of its volume. The alveolar epithelial cells that
synthesize milk are highly specialized, polarized and differ-
entiated cells. Their function is to synthesize, package and
export the key constituents of milk. At least five pathways are
involved in the formation of milk in the tubuloalveolar struc-
tures of the mammary gland. The first, which is particularly
relevant to the topic of this review article, is the secretion of
monovalent cations and water. Current understanding is that
water is secreted across the mammary epithelium in a trans-
cellular manner, in response to an osmotic gradient produced
largely by the lactose content of the milk [6, 7]. Water is
essentially drawn across the alveolar cells by the concentra-
tion gradient created by osmotically active milk sugars. This
process is followed by the transport of immunoglobulins, milk
lipids, milk proteins and other buffers and electrolytes. The
processes involved in milk production are discussed in the
following section.
Milk Production
Five distinct processes are involved in themammary epithelium
in the secretion of milk (Fig. 3). These pathways operate in
parallel to transform precursors derived from the blood or
interstitial fluid into milk constituents. Although the biochem-
ical processes involved are fundamentally the same in all mam-
mals, differences in their relative rates and, in some cases, in the
nature of the products synthesized result in milks whose com-
position differs widely from one species to another. Some of the
milk secretion pathways, e.g., exocytosis of protein-containing
vesicles and transcytosis of immunoglobulins, are similar to
processes in many exocrine organs. In contrast, the
mechanism for fat secretion is unique to the mammary
gland. Four secretory processes are synchronized in the
mammary epithelial cell of the lactating mammary
gland: exocytosis, lipid synthesis and secretion, trans-
membrane secretion of ions and water and transcytosis
of extra-alveolar proteins such as immunoglobulins, hor-
mones and albumin from the interstitial space. A fifth
pathway, the paracellular pathway, allows the direct
transfer of materials between the milk space and the
interstitial space. This pathway is open in the pregnant
gland and allows the transfer of molecules at least as
large as intact immunoglobulins. It is closed in the fully
lactating gland providing a tight barrier between the
milk and interstitial spaces. This barrier opens again in
the presence of mastitis and during involution [8, 9].
Breast Cancer
Breast cancer refers to tumors that form in tissues of the
mammary gland. The most common type of breast can-
cer is ductal carcinoma, which begins in the lining of
the milk ducts. Another common type of breast cancer
is lobular carcinoma, which occurs in the lobules of the
breast. Invasive breast cancer refers to metastatic cancer
Fig. 3 Alveolar cell from
lactating mammary gland. TJ
tight junction;GJ gap junction;D
desmosome; SV secretory vesicle;
FDA fat-depleted adipocyte; PC
Plasma Cell; BM basement
membrane; ME cross section
through process of myoepithelial
cell; RER rough endoplasmic
reticulum. See text for
explanation of secretory pathways
I (exocytosis), II (lipid), III
(apical transport), IV
(transcytosis) and V (paracellular
pathway)
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that has spread from breast ducts or lobules to sur-
rounding normal tissues. The global burden of breast
cancer exceeds all other cancers and the incidence rates
of breast cancer are constantly increasing. Breast cancer
is the second most common cancer worldwide after lung
cancer, the fifth most common cause of cancer death,
and the leading cause of cancer death in women. Al-
though breast cancer affects both men and women, the
incidence of male breast cancer is very rare. Up-to-date
statistics from the National Institutes of Health suggest
that in the United States there were 232,340 (female)
and 2,240 (male) new cases resulting in 39,620 deaths
in females and 410 in males.
This article does not focus on the usual suspects in
breast cancer. We do not discuss the recent data on
BRCA mutations, the expression of HER2, the estrogen
receptor, the progesterone receptor or new adjuvant
therapies. The aim of this article is to discuss the role
of aquaporins in mammary gland physiology and review
the recent information on aquaporins in cancer.
Aquaporin Water Channels
The fact that water has the ability to cross the hydrophobic
membrane and enter (and leave cells) had been known for
decades, but the mechanism was somewhat of a paradox. The
paradox was solved by the discovery of a family of 28 kDa
membrane transporters with high permeability for water [10].
The first of these proteins to be discovered was initially called
“CHIP28” but is now known as aquaporin 1 (AQP1) [10, 11].
Transfection of cells with AQP1 increased membrane perme-
ability to water by 50x. The discovery of aquaporins led to the
award of the Nobel Prize in chemistry to Dr. Peter Agre in
2003.1, 2 A transcript of his Nobel lecture was published in
Bioscience Reports in 2004 [12]. Following the initial discov-
ery a number of advancements have been made in the field.
Aquaporins are a family of membrane bound proteins that are
believed to be ubiquitously expressed in cellular and intracel-
lular membranes. They are extensively distributed in micro-
organisms [13], animals [14–16] and plants [17–19]. They are
small transmembrane proteins that are expressed in a variety
of epithelial tissues where they are responsible for regulating
rapid water movement across epithelial barriers driven by
osmotic gradients. Initially, the main role of aquaporins was
believed to be water and small solute transport across epithe-
lial and endothelial barriers [20, 21]. It is now known that
aquaporins are found in a wide range of non-epithelial/
endothelial cells from acinar cells to chondrocytes [22–24],
leukocytes to astrocytes, and in a wide range of reproductive
organs [25–27]. Thus aquaporins appear to be present in most,
if not all, cell types. Furthermore, aquaporins serve important
functions in a wide range of processes such as cell division,
cell migration, cellular volume regulation and apoptosis. The-
se are clearly of importance when considering the pathogen-
esis of carcinomas. Despite this ubiquitous expression and
fundamental importance in cell biology, genetic deletion of
AQP genes has a less dramatic effect on animal survival than
may be expected. Transgenic mice lacking AQP1 water chan-
nels survive but they have severely impaired urinary concen-
trating ability [28] and lack of a functional AQP2 gene leads to
a rare form of nephrogenic diabetes insipidus [29]. Survival in
the absence of specific aquaporins may be because of the
phenotypic adaption that takes place; for example, genetic
knock-out of AQP1 leads to up-regulation of other aquaporins
such as AQP4, AQP7 and AQP8, at least in some tissues [30].
Mammalian aquaporins are located at strategic membrane
sites in endothelia and a variety of epithelia, most of which
have well-defined physiological functions in fluid absorption
or secretion [31]. To date, 13 members of the aquaporin gene
family have been identified in humans: AQP0-AQP12 [32].
Animal genome projects have also confirmed the presence of
multiple aquaporin genes encoding distinct protein isoforms.
The proteins encoded by aquaporin genes have been classified
into two major groups based on their substrate permeabilities:
1) the classical water permeable aquaporins are permeated by
water and include AQP1, AQP2, AQP4, AQP5 and AQP8
[14]; 2) the water and small solute permeable aquaglyceropo-
rins exhibit permeability to water and a range of small neutral
solutes including substances such as glycerol and urea. Aqua-
glyceroporins include AQP3, AQP7, AQP9 and AQP10 [14,
33]. Several aquaporins, including (AQP1, AQP4, AQP5 and
AQP8) have also been proposed to facilitate entry of gases
such as CO2, NO and ammonia to cells, but this important
topic is discussed and reviewed elsewhere [34, 35]. The more
controversial suggestion that some aquaporins (AQP1 for
example) conduct small cations (e.g., Na+ and K+ [36, 37])
is disputed by the groups’ of Agre and Pohl [34, 38].
Hormone Regulation of Aquaporins
The physiological advantage of membrane expression of ion
channel and porin proteins compared to the evolution of
“leaky” membranes is that membrane permeability can be
precisely and dynamically controlled by variations in protein
expression and activity. This allows for changing membrane
water permeability in response to changing osmotic environ-
ment or the physiological need. This is achieved in two ways,
firstly the permeability of the aquaporin channels themselves
is variable, being strongly dependent on the molecular weight
1 The Nobel Prize in Chemistry 2003 was awarded “for discoveries
concerning channels in cell membranes” jointly with one half to Peter
Agre “for the discovery of water channels” and with one half to Roderick
MacKinnon “for structural and mechanistic studies of ion channels”.
2 http://www.nobelprize.org/nobel_prizes/chemistry/laureates/2003/
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of the osmolytes in the aqueous solution to which the channel
is exposed [39]. Secondly, functional expression can be dy-
namically regulated. Although little data exists on this in
mammary gland tissue, there are several examples of this
phenomenon elsewhere. The most commonly observed ex-
ample is in the kidney collecting duct water (principle cell)
where permeability increase is induced by arginine-
vasopressin induced phosophorylation via V2-R receptors
[40–43]. This system is a key step in regulation of re-
absorption and thus urinary volume control and the regulation
of body water balance. The cellular mechanism is understood
in some detail and involves the translocation of protein to the
cellular membrane, a mechanism, which is significantly faster
than protein synthetic generation of new protein de novo.
During brain edema and in joint diseases such as osteoarthri-
tis, synovitis and rheumatoid arthritis aquaporin expression
changes as an apparent adaptation to changes in the local
osmotic environment [24, 44–46]. Furthermore, steroid hor-
mones increase AQP1 expression in both peribronchiolar and
uterine vascular endothelial tissues as a part of tissue fluid
management [47, 48].We will also discuss, below, howAQP1
is thought to be involved in estrogen mediated angiogenesis in
the mammary gland and outline how increases in AQP3
expression promote FGF-2 stimulated migration of breast
cancer cell lines.
Immunolocalization of Aquaporins in Rat, Mouse,
Human and Bovine Mammary Glands
Until recently nothing was known about the expression of
aquaporins in the mammary glands of rodents, humans and
dairy animals. Recent immunohistochemical studies of aqua-
porins in the rat and mouse mammary gland have confirmed
the presence of AQP1 and AQP3 proteins in both species [49].
Matsuzaki and co-workers also used RT-PCR to study the
expression of AQP1, AQP2, AQP3, AQP4, AQP5, AQP6
and AQP7 in the rat mammary gland [49]. In addition to
AQP1 and AQP3 they found evidence for the presence of
AQP4, AQP5, AQP7 and AQP9 transcripts in the rat mam-
mary gland. However, they did not use antibodies to localize
these proteins to specific tissues within the breast.
Work using human tissue microarrays has provided direct
immunohistochemical evidence for the presence of AQP1 and
AQP3 in human mammary glands [41, 50] (Fig. 4). AQP1 has
been located in both the apical and basolateral membranes of
α1 subunit Na, K-ATPase
AQP3 Control
AQP1
100um
Fig. 4 Expression of the α1 subunit of Na, K-ATPase, AQP1, AQP3 in normal human breast samples represented on a CHTN human tissue microarray
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capillary endothelia in the rodent mammary gland [49]. AQP3
has been located immunohistochemically in basolateral mem-
branes of secretory epithelial cells and intralobular and interlob-
ular duct epithelial cells in rat and mouse mammary tissue [49].
Although the expression of mRNA transcripts encoding AQP4,
AQP5, AQP7 and AQP9was demonstrated in rodent mammary
by RT-PCR, the presence of the corresponding proteins was not
investigated and the presence of aquaporins 4, 5 and 7 in the
rodent mammary gland was not studied using immunohisto-
chemical methods [49].
Physiological Relevance of Aquaporins to Milk
Production
Milk is a secreted body fluid that consists of water plus lipids,
electrolytes, vitamins, sugars and specific milk proteins. The
delivery ofwater to themammary gland by the circulatory system
and the movement of water across endothelial and epithelial
barriers are critical for milk synthesis and secretion in lactating
animals. There is published information on sodium and chloride
transport in mammary epithelia [51]. However, the functional
anatomy of the mammary gland has not been extensively studied
in the context of water transport across endothelial and epithelial
barriers and bulk fluid movement in lactating animals. Conse-
quently, very little published information is available; AQP1 and
AQP3 proteins have been shown to be present in the capillary
endothelia and mammary epithelial cells, respectively [49]. Sim-
ilar observations suggest that AQP1 and AQP3 proteins are also
present in non-lactating human mammary glands [41, 50]. Data
recently published on aquaporins in the bovine mammary gland
[52] confirm some of the recent observations made by [49] in
rodent mammary glands and similar observations in human
mammary glands [41, 50]. Bovine data [52] also confirm the
presence of these proteins in the bovine mammary gland, al-
though in distinct cellular locations. A striking and previously
unreported expression of AQP1, at high abundance, is also
observable in myoepithelial cells underlying teat duct epithelia
[52]. The physiological reason for this is at present unknown, but
high AQP1 levels in this location may contribute to increased
permeability of teat duct epithelia in the lactating bovine mam-
mary gland. The relative abundance of the protein also appears to
represent a distinct aspect of differentiation of myoepithelial cells
in this location, compared with those surrounding the acini.
Goats’ milk is known to contain numerous cell fragments
known as “christiesomes” which originate from secretory epi-
thelial cells of themammary gland [53, 54]. These cell fragments
are known to contain intact and well-preserved endoplasmic
reticulum, mitochondria and lipid droplets. Furthermore, they
are capable of triglyceride synthesis. Although cows’ milk has
been shown to contain very few cellular fragments, it does
contain different and denser particles containing fewer vesicles
and numerous microvillus-like protrusions on one side—known
as “sunbursts” [53]. Although it has been suggested that these
particles are residues of dead cells, it is possible that these
fragmented cytoplasm-containing entities contain membrane
proteins, which are targeted to the apical membranes of mam-
mary secretory epithelial cells. Recent studies have provided
evidence for urinary excretion of AQP2 water channel proteins
during pregnancy [55, 56]. Biochemical analysis of
“christiesomes” and “sunbursts” should reveal if these cellular
fragments contain membrane proteins of the apical membranes
of alveolar epithelial cells. Comparing this data with published
data from rodent studies clearly indicates that some of the
aquaporins expressed in the lactating mammary tissues were
found in expected anatomical locations; immunohistochemical
labeling in the rat mammary gland suggests that AQP1 is local-
ized to the capillaries and AQP3 is localized to the basolateral
membranes of the alveolar secretory cells. These results suggest
that aquaporins are present in lactating mammary glands and
may be participants in the control of milk water content by
diluting the sugar, protein and lipid contents of milk to an
isotonic solution as it descends through the teat duct system.
This data has provided interesting new information about the
possible regulation of water homeostasis in the mammary gland.
Milk yield is ofmajor economic importance to the dairy industry.
Therefore, it is necessary to understand the underlyingmolecular
physiology involved in fluid movement in lactation.
Aquaporins and Cancer
Aquaporins are more than just passive water and small solute
channels in biological membranes [57]. They are actively
regulated and increasingly implicated in a number of impor-
tant clinical disease states [58]. Recent evidence suggests that
aquaporins are also involved in cell migration [59], angiogen-
esis [60], and tumor growth [61]. These water channel pro-
teins are strongly expressed in tumor cells of different origins,
particularly aggressive tumors [62]. AQP1 is ubiquitously
expressed in endothelia of many human tissues [41]. Immu-
nohistochemical and histomorphometric studies have con-
firmed the presence of AQP1 in endothelial barriers of almost
all human tissues as well as many epithelial barriers involved
in absorptive and secretory functions [41]. AQP1 is also
present in tumor vascular endothelium [62]. Interestingly,
targeted AQP1 gene disruption impairs angiogenesis and cell
migration and AQP1-null mice show defective tumor angio-
genesis resulting from impaired endothelial cell migration [62,
63]. AQP-expressing cancer cells show enhanced migration
in vitro and greater local tumor invasion, tumor cell extrava-
sation, andmetastases in vivo thanAQP1-null transgenicmice
[62]. AQP-dependent cell migration may involve AQP-
facilitated water influx into lamellipodia at the front edge of
migrating cells [63]. High throughput studies using tissue
microarrays (TMAs) have shown that AQP1 is an excellent
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marker of microvasculature but it is heterogeneously
expressed in different human tumors and is not necessarily
expressed in all neoplastic cells [64]. It has been proposed that
increased AQP1 expression in some human adenocarcinomas
may be a consequence of angiogenesis and important for the
formation or clearance of tumor edema [64]. There is growing
data in the literature concerning the involvement of AQP1 and
AQP4 in human brain tumor growth and edema formation
[61, 65]. These studies suggest that the presence of AQP1, but
not AQP4, enhances glioma growth and migration, while
AQP4 enhances cell adhesion highlighting differential biolog-
ical roles for AQP1 and AQP4 in gliomas [66].
Aquaporins have therefore been proposed as novel pharma-
cological targets in cancer and associated edematous states [67].
Potentially, block of aquaporins could limit angiogenesis and
inhibit tumor growth and metastasis. Therefore it has been
suggested that novel therapeutic strategies approaches may be
developed by antagonizing their biological activity [65]. It
should be noted that pharmacological inhibition of aquaporins
could have a greater protective effect than that resulting from
genetic deletion, because there is less opportunity for adult cells
to exhibit the phenotypic switch of aquaporin expression
discussed above in APQ1 knock-out studies. Consequently,
there is growing interest in aquaporin-based diagnostics [68]
and the development of small-molecule aquaporin modulators
for treating various clinical states including brain edema, neuro-
inflammation, glaucoma, epilepsy, cancer, pain, and obesity [58].
Aquaporins in Breast Cancer
Studies on the role of CCAAT/enhancer binding protein (C/
EBP) family of bZIP transcription factors (particularly C/
EBPβ) in mammary gland development and breast cancer have
shown that targeted deletion of C/EBPβ isoforms results in
severe inhibition of lobuloalveolar development, blocks func-
tional differentiation, and induces changes in ductal morphogen-
esis. The loss of C/EBPβ isoforms results in altered expression
of a number of membrane proteins, transporters and molecular
markers, including the progesterone, estrogen, prolactin recep-
tors and several transporter proteins (NKCC1 and AQP5) [69].
This was one of the early studies that implicated AQP5 in
mammary gland development [69]. Further studies investigated
the distribution of AQP1 in tumors of the prostate, colon, lung,
breast and ovary using TARP multi-tumor Tissue TMAs and
CHTN (Cooperative Human Tissue Network) TMAs [64].
AQP1 expression was higher in advanced mammary and colo-
rectal carcinomas where AQP1 immunoreactivity was also seen
in some neoplastic tumor cells [64]. Subsequent studies from
our laboratory investigated expression of AQP1, the GLUT1
glucose transporter and Na, K-ATPase in canine mammary
glands and mammary tumors [70]. We investigated the expres-
sion of these proteins in normal canine mammary glands and in
benign and malignant mammary tumors, using immunohisto-
chemistry and semi-quantitative histomorphometry. Interesting-
ly, AQP1 immunoreactivity was absent from the majority of
canine tumor specimens studied. However, this could have been
due to the lack of antibody cross-reactivity. The antibodies used
in the study were raised against rat AQP1 and could have cross-
reacted poorly with their with canine AQP1 counterparts [70].
Otterbach and co-workers used immunohistochemical
techniques to investigate the expression of AQP1 in 203
invasive breast carcinomas with long-term follow up data
[71]. AQP1 expression was seen in 11 tumors (5.4 %) and
showed a highly significant correlation with high tumor grade,
medullary-like histology, “triple-negativity”, cytokeratin 14
and smooth muscle actin expression. The authors used uni-
variate analysis to show that AQP1 was significantly associ-
ated with poor prognosis. They also usedmultivariate analysis
to demonstrate that AQP1 protein expression is an indepen-
dent prognostic marker if the tumors are properly stratified by
age, tumor size, lymph node status, histological grade, ER
status and CMF therapy. Based on these results the investiga-
tors suggested that AQP1 expression is a characteristic feature
of aggressive basal-like breast carcinomas [71].
No genome wide transcriptomic studies have specifically
investigated changes in aquaporins in breast cancer, however,
most of the common microarray RNA chips, including
Affymetrix, Agilent and Illumina include multiple probe sets
for the aquaporins. Analysis over a range of different breast
cancer cell lines and experiments listed in the Gene Expression
Atlas [72] reveals changes in transcript abundance ofmany of the
aquaporins (see Fig. 5). Many of these are decreased in expres-
sion in cancerous tissue, perhaps revealing that some of the
observed increases in aquaporins protein expression could result
from post-translational changes. Casey et al. [73] performed a
large microarray analysis of genome-wide expression in normal
(breast reduction) and breast cancer patients. Both epithelial
tumor and stromal tumor samples were analyzed using the pop-
ular Affymetrix Human Genome U133A 2.0 Array. The raw and
processed data are publically available in the Gene Expression
Atlas (E-GEOD10797) and the Gene Expression Omnibus data-
base (Accession no. GSE10797: http://www.ncbi.nlm.nih.gov/
geo/geo2r/). Expression data is presented for many of the
possible aquaporins isoforms (AQP1, AQP2, AQP3, AQP4,
AQP5, AQP6, AQP7, AQP8 and AQP9). There is considerable
variation between individual patients, with some showing very
large increases in some isoforms of channel. The most notable
observation, however, is the differences between epithelial and
stromal tumor tissue; whilst there are no significant differences
between any of the aquaporin transcripts in normal breast tissue;
AQP1, AQP8, AQP4, AQP6 and AQP9 are all significantly
higher in stromal tumor tissue, implying a considerable change
in cellular phenotype. There is no evidence from this
transcriptomic data of a phenotypic switch from one isoform to
another to that observed with genetic deletion [30].
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As discussed earlier, AQP1 is a well-established marker of
microvessels. AQP1 has been proposed as a mediator of
estrogen-induced angiogenesis in human breast cancer. A re-
cent study has shown that AQP1 plays a crucial role in
estrogen-induced tubulogenesis of vascular endothelial cells
[60] providing fresh new insight into the molecular mecha-
nisms underpinning the angiogenic effects of estrogen. The
authors found that expression of AQP1 in blood vessels of
human breast carcinoma tissues were significantly higher than
controls [60], confirming the observations of several earlier
studies [64, 71].
A genetic study in Germany investigated the prognostic
relevance of the AQP5 -1364C>A polymorphism in primary
breast cancer [74]. Samples from a total of 107 patients with
early stage breast cancer were analyzed in order to test the
hypothesis that this polymorphism is associated with
lymphogenous and hematogenous tumor cell dissemination
and overall survival. SNPs in AQP5 were not found to be
associated with hematogenous or lymphogenous tumor cell
spread. However, there was an association between SNPs in
AQP5 and progesterone receptor positivity, which might have
implications for future adjuvant treatment [74].
A study conducted inNanjing, China screened the expression
profile of AQP0-12 in breast cancer tissues and corresponding
normal tissues by using RT-PCR, western blotting and immu-
nohistochemistry [75]. AQP1, AQP3, AQP4 and AQP5
Fig. 5 Differential expression of
AQPs in human mammary
glands, breast tissues and cell
lines. We analysed the aquaporin
gene expression patterns using the
Gene Expression Atlas (GXA:
http://www.ebi.ac.uk/gxa) as
described previously [72]. The
latest release 2.0.21.3 (Ensembl
version 72) comprising a total of
2,841 experiments, 88,280 assays
and 16,398 conditions. The
database hosts publicly available
gene expression data from the
ArrayExpress archive. The
database was queried for all
aquaporin ‘genes’ that are
differentially expressed breast
tissue. The analysis was restricted
to Homo sapiens. Each row is an
AQP gene and each column is a
condition. The expression
patterns are denoted by blue or
red color. Blue indicates under
expression and red indicated over
expression of a particular AQP
gene. Note that non-differentially
expressed results are not included.
Number inside the square or
triangle indicates that the number
of experiments where the
particular AQP gene was under or
over expressed.
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exhibited differential expression compared to normal tissue.
Interestingly, this study found that AQP5 was expressed mainly
in cell membranes of mammary carcinomas, with AQP5 being
not detectable in normal breast tissues. Furthermore, expression
ofAQP5was found to be associatedwith cellular differentiation,
lymph node invasion, and tumor staging [75].
Subsequent studies on breast cancer cell lines have shown
that AQP5 is a marker protein for proliferation and migration
of human breast cancer cells [76]. Jung and co-workers de-
tected AQP5 mRNA and protein in the human breast cancer
cell lines MCF7 and MDA-MB-231 by RT-PCR and immu-
noblotting. Immunolabeling of AQP5 was seen in ductal
epithelial cells of human breast tissues but the apical polarity
of AQP5 in ducts was lost. The prominent expression of
AQP5 and the loss of polarity of ductal epithelial cells were
associated with the progression of breast carcinoma. The
authors concluded that AQP5 over-expression plays a role in
cell growth and metastasis in human breast cancer [76].
Several studies have also reported on the expression and
functional role of AQP3 in breast cancer cell lines. A very
recent study has shown that AQP3 is required for FGF-2-
induced migration of human breast cancers [77]. The authors
used MDA-MB-231 and Bcap-37 cell lines as models and
inhibited the expression of AQP3 expression using lentiviral
constructs that stably express shRNA against the mRNA
encoding AQP3. Stimulation with FGF-2 treatment increased
AQP3 expression and induced cell migration. Silencing AQP3
expression inhibited FGF-2 induced cell migration. The study
concluded that AQP3 is required for FGF-2-induced cell mi-
gration in cultured human breast cancer cells. These findings
also highlight the importance of FGFR-PI3K and FGFR-ERK
signaling in FGF-2-induced AQP3 expression.
Finally, Trigueros-Motos et al., [78] used the capecitabine
catabolite 5′-deoxy-5-fluorouridine (5′-DFUR) (a nucleoside
analog used in the chemotherapy of solid tumors) to demon-
strate that AQP3 is required for cytotoxic activity of 5′-DFUR
in the breast cancer cell line MCF7 and that this aquaporin is
implicated in cell volume increase and cell cycle arrest. Thus,
it would appear that AQP3 ismore than a marker and a passive
channel. Its function is actually important for chemotherapy.
Conclusions
The mammary gland remains an enigma. The distinctive devel-
opmental aspects and complex regulation by hormones and
growth factors has made the study of the mammary gland
function a major focus of research for scientists from many
different biological and biomedical disciplines. The increased
incidence of breast cancer is another important reason for study-
ing the mammary gland. A number of studies have attempted to
identify specific genes required for the functional development
of mammary epithelium [79]. However, very few studies have
examined the potential contribution of aquaporins to milk pro-
duction. The altered expression of a number of molecular
markers, including the progesterone, estrogen, and prolactin
receptors, the Na/K/2Cl cotransporter proteins (NKCC1) and
aquaporin 5 (AQP5), and several markers of skin differentiation
(Sprr2A and keratin 6) has been reported in breast cancer [69].
The identification of AQP5 expression in neoplastic breast
epithelium preceded subsequent reports of other aquaporins in
rat, mouse [49] and bovine mammary glands [52]. The studies,
cited in this review article, suggest that several aquaporin pro-
teins collaborate in the production of milk in the mammary
gland. There is also emerging evidence to suggest that aquapo-
rins play important roles in breast cancer development.
From a physiological perspective, future studies will need
to determine if additional aquaporins are involved at different
stages of lactation and correlate the expression of these with
the expression of milk protein genes and proteins. A better
understanding of the molecular mechanism involved in milk
production will have significant benefits for animal breeding
programmes.
From a pathophysiological perspective, there is an almost
universal observation that AQP protein expression increases
in cancer. The biological implications of this are not really
completely clear but the information available supports the
hypothesis that aquaporins are implicated in neoplastic trans-
formation in the breast and other organs. This may be due to
the involvement of aquaporins in angiogenesis or cell migra-
tion, but an additional intriguing possibility is that
aquagylceroporins, in particular, could be coupled to the cel-
lular metabolism of tumor-committed cells. Entry of glycerol
through channels such as AQP3 can increase availability of
intracellular ATP in some cell types [80] and therefore its
inhibition could therefore slow proliferation. The role of aqua-
glyceroporins in the mammary gland should be considered in
the context of lactation and neoplastic transformation. The
role of aquaglyceroporins may not be limited to cell prolifer-
ation. The entry of glycerol into mammary epithelial cells is
also likely to be important for lipogenesis which is equally
important for mammary gland health and disease.
Further work is required to determine whether aquaporins
are viable therapeutic targets or reliable diagnostic and prog-
nostic biomarkers, understand the functional roles of aquapo-
rins in breast cancer and determine whether these proteins can
be targeted in new anti-cancer therapies.
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